IYH - iShares U.S. Healthcare ETF

NYSEArca - NYSEArca Delayed Price. Currency in USD
181.19
+0.19 (+0.10%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close181.00
Open180.56
Bid180.83 x 800
Ask184.58 x 800
Day's Range180.21 - 182.00
52 Week Range168.42 - 204.83
Volume72,868
Avg. Volume119,824
Net Assets2.38B
NAV181.07
PE Ratio (TTM)N/A
Yield1.84%
YTD Return0.28%
Beta (3Y Monthly)1.03
Expense Ratio (net)0.43%
Inception Date2000-06-12
Trade prices are not sourced from all markets
  • Can Q1 Earnings Lift Healthcare ETFs Higher?
    Zacks4 days ago

    Can Q1 Earnings Lift Healthcare ETFs Higher?

    With negative earnings revisions, the healthcare sector is expected to witness earnings growth of 1.8% in the first quarter, suggesting smooth trading for healthcare ETFs.

  • UnitedHealth Falls Despite Q1 Beat, Healthcare ETFs in Focus
    Zacks5 days ago

    UnitedHealth Falls Despite Q1 Beat, Healthcare ETFs in Focus

    UnitedHealth Group reported robust first-quarter 2019 results. The company breezed past the Zacks Consensus Estimate on both earnings and revenues and raised its full-year forecast.

  • JNJ Beats, Ups Sales Growth View: Healthcare ETFs in Focus
    Zacks5 days ago

    JNJ Beats, Ups Sales Growth View: Healthcare ETFs in Focus

    Johnson & Johnson continued its long streak of earnings beat and also outpaced revenue estimates. Though it raised the guidance for full-year sales growth, it tightened the earnings per share forecast.

  • Health Day Checkup of Medical ETFs: 5 Top Picks
    Zacks18 days ago

    Health Day Checkup of Medical ETFs: 5 Top Picks

    M&A activity, approval of novel drugs and earnings growth in Q1 put healthcare ETFs in a decent spot.

  • ETF Trends2 months ago

    A Healthy Outlook For Healthcare ETFs

    For example, the iShares US Healthcare ETF (IYH) , which tracks the Dow Jones U.S. Health Care Index, is higher by about 7% this year. The $2.34 billion IYH devotes about 53% of its combined weight to pharmaceuticals and medical equipment stocks. Consequently, investors may also turn to defensive sectors that are less economically sensitive, such as health care.

  • Healthcare ETFs in Focus Ahead of Q4 Earnings
    Zacks3 months ago

    Healthcare ETFs in Focus Ahead of Q4 Earnings

    With lower negative earnings revisions, the healthcare sector is expected to witness earnings growth of 7.7% in the fourth quarter, suggesting continued outperformance for healthcare ETFs.

  • JNJ Beats, Offers Bleak Outlook: Health Care ETFs in Focus
    Zacks3 months ago

    JNJ Beats, Offers Bleak Outlook: Health Care ETFs in Focus

    Johnson & Johnson expects its sales growth to slow down this year due to pricing pressures and generic-drug competition for its pharmaceutical division. This has put healthcare ETFs in focus.

  • UnitedHealth Pops on Solid Q4: Healthcare ETFs to Buy
    Zacks3 months ago

    UnitedHealth Pops on Solid Q4: Healthcare ETFs to Buy

    ETFs having the largest allocation to UnitedHealth has been in focus post its solid result.

  • ETF Trends4 months ago

    Some Value Remains With HealthCare ETFs

    Compared to other sectors, healthcare was sturdy in 2018 and while the sector looks close to being fairly valued, the group could offer more upside this year. The Health Care Select Sector SPDR ETF (XLV) , the largest healthcare ETF by assets, gained 6.30% last year. XLV allocates about two-thirds of its combined weight to pharmaceuticals and biotechnology stocks.

  • Best ETFs: After Buying A Top ETF, Don't Forget These 2 Sell Rules
    Investor's Business Daily4 months ago

    Best ETFs: After Buying A Top ETF, Don't Forget These 2 Sell Rules

    Even the best ETFs can cause serious pain for investors when buys are made in the middle of a bear market. Read The Big Picture column for market guidance.

  • 10 Top-Ranked ETFs That Crushed the Market in 2018
    Zacks4 months ago

    10 Top-Ranked ETFs That Crushed the Market in 2018

    While there have been losers in most corner of the space, several ETFs still managed to end the year in green and are likely to continue outperforming in 2019 too.

  • Best ETFs: With Health Care Leading, IShares ETF Comes Out A Winner
    Investor's Business Daily4 months ago

    Best ETFs: With Health Care Leading, IShares ETF Comes Out A Winner

    In a lackluster year for stocks, health care proved to be one of the best sectors, a big reason why iShares U.S. Healthcare is now among the best ETFs.

  • ETF Trends5 months ago

    10 Sector ETFs That Could Stand Out in the New Year

    The U.S. equity rally is beginning to lose steam and investors should not expect markets to maintain their breakneck spurt of yesteryear. Nevertheless, traders may still find value in some battered sectors ...

  • ETF Trends5 months ago

    Stable, Defensive Sector ETFs for a Wobbly Market

    As U.S. markets continue to wobble, investors who want to stay in the game can look to defensive sector-related ETFs for a more steady approach. “If the sell-off continues and it deepens, it’s going to ...

  • ETF Trends5 months ago

    Leveraged Healthcare ETF Gains On Midterm Election Results

    Even as the Democrats retook control of the House of Representatives and the Republicans maintained majority in the Senate, healthcare ETFs were also big winners following the 2018 Midterm Election results. ...

  • ETF Trends6 months ago

    Healthcare ETFs in Focus Ahead of Election Day

    Count the iShares US Medical Devices ETF (NYSEArca: IHI) and the iShares US Healthcare ETF (NYSEArca: IYH) among the healthcare exchange traded funds that could be affected by the results of the upcoming ...

  • Pfizer’s Market Cap and Shareholding Pattern
    Market Realist6 months ago

    Pfizer’s Market Cap and Shareholding Pattern

    As we discussed earlier, Pfizer’s (PFE) product portfolio is classified into two segments—the Innovative Health segment and the Essential Health segment. In this part, we’ll discuss Pfizer’s market capitalization and shareholding pattern.

  • ETF Trends6 months ago

    Health Care ETFs Retreat on DOJ Approval of Aetna-CVS Merger

    The Department of Justice issued a preliminary approval for CVS Pharmacy to acquire health care insurance company Aetna, possibly paving the way for transformative changes in the industry as cries for more affordable care emanating from consumers and regulators get louder. The Health Care Select Sector SPDR ETF (XLV) slid 0.42% as of 11:45 a.m. ET, Vanguard Health Care ETF (VHT) fell 0.54%, iShares US Medical Devices ETF (IHI) was down 1.21%, and iShares US Healthcare ETF (IYH) slid 0.55%. As part of the approval process, the DOJ set forth the condition that Aetna had to divest itself from its Medicare Part D drug plan, which it eventually sold to WellCare Health Plans for an undisclosed amount late last month.

  • Best ETFs & Stocks From the Top Sector of Q3
    Zacks7 months ago

    Best ETFs & Stocks From the Top Sector of Q3

    Healthcare was the best-performing sector of the third quarter, jumping 14.1% - its highest quarterly gain since the first quarter of 2013.

  • AbbVie’s Dividend Has Risen 140% since 2013
    Market Realist7 months ago

    AbbVie’s Dividend Has Risen 140% since 2013

    AbbVie (ABBV) announced its fourth-quarter dividend yield of 4.09%. On September 7, AbbVie announced a dividend of $0.96 per share to its shareholders of record on October 15.

  • Thermo Fisher to Offer Complete Cannabis Testing Solutions
    Market Realist7 months ago

    Thermo Fisher to Offer Complete Cannabis Testing Solutions

    Thermo Fisher Scientific (TMO) announced on September 7, 2018, that the company offers end-to-end analytical solutions that comply with cannabis testing standards as defined by Health Canada.

  • How Abiomed’s Revenue Trended in the First Quarter
    Market Realist8 months ago

    How Abiomed’s Revenue Trended in the First Quarter

    As discussed earlier, Abiomed (ABMD) reported revenues of $180.0 million in Q1 2019, a 36% increase as compared to revenues of ~$132.5 million in the first quarter of 2018.

  • Investopedia8 months ago

    3 ETFs for Johnson & Johnson's Healthy Breakout

    Johnson & Johnson (NYSE: JNJ), one of the world's largest healthcare companies, has underperformed the broader market in 2018. The company's stock is down 3.66% year to date (YTD), while the Standard and Poor's 500 index (S&P 500) is up roughly 7%. David Katz, chief investment officer at Matrix Asset Advisors, told Reuters, "We are much more upbeat about Johnson & Johnson today than we were six months ago.

  • 4 Sector ETFs to Tap at New Highs
    Zacks8 months ago

    4 Sector ETFs to Tap at New Highs

    While there are winners in many corners of the stock market, investors should tap the sectors that are expected to continue moving higher in the weeks ahead.

  • Estimates and Recommendations for Allergan in August
    Market Realist8 months ago

    Estimates and Recommendations for Allergan in August

    Analysts expect Allergan’s (AGN) adjusted EPS to be $16.29 on revenue of $15.53 billion in 2018, a 2.6% fall in revenue compared to $15.94 billion in 2017. Analysts expect the company’s adjusted net income to fall in 2018 mainly due to a fall in its gross profit margin and partially offset by a decrease in its selling, general, and administrative expenses as well as its research and development expenses. Allergan’s stock price has fallen nearly 20.2% over the last 12 months, but it’s risen ~12.8% year-to-date in 2018.